健康関連QOLが生存へ与える影響の同時モデリングによる評価

スポンサーリンク

概要

• 論文の詳細を見る
• 2002-09-01

著者

• OHASHI Yasuo

  Biostatistics Sciences, School of Health Science and Nursing Biostatistics, University of Tokyo

• Yoshimura Kenichi

  Biostatistics University Of Tokyo

• Ohashi Yasuo

  Biostatistics University Of Tokyo

関連論文

• Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
• Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
• A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate : a randomized, double-masked trial
• Efficacy and tolerability of once-weekly administration of 17.5mg risedronate in Japanese patients with involutional osteoporosis : a comparison with 2.5-mg once-daily dosage regimen
• Therapeutic effects of alendronate 35mg once weekly and 5mg once daily in Japanese patients with osteoporosis : a double-blind, randomized study
• Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
• 健康関連QOLが生存へ与える影響の同時モデリングによる評価
• Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study

スポンサーリンク